Iqvia Holdings (IQV) Non-Current Assets (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Non-Current Assets came in at $23.7 billion in Q2 2026, up 6.14% year-over-year from $22.3 billion in Q2 2025, and up 0.85% quarter-over-quarter from $23.5 billion in Q1 2026.
Analysis
Iqvia Holdings (IQV) Non-Current Assets (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Non-Current Assets across 15 years of filings, most recently posting $23.7 billion for Q2 2026.
- In Q2 2026, Non-Current Assets rose 6.14% year-over-year to $23.7 billion; the TTM figure through Jun 2026 stood at $93.6 billion (up 8.38% YoY), while the FY2025 annual figure was $23.7 billion, up 12.46% from the prior year.
- Non-Current Assets came in at $23.7 billion for Q2 2026 at Iqvia Holdings, up from $23.5 billion in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $23.7 billion in Q4 2025 to a low of $19.5 billion in Q3 2022.
- Average Non-Current Assets over 5 years is $21.3 billion, with a median of $21.0 billion recorded in 2024.
- Year-over-year, Non-Current Assets retreated 0.14% in 2022 and grew 12.46% in 2025.
- Over 5 years, Non-Current Assets stood at $20.4 billion in 2022, then grew by 3.58% to $21.1 billion in 2023, then dropped by 0.07% to $21.1 billion in 2024, then rose by 12.46% to $23.7 billion in 2025, then slipped by 0.17% to $23.7 billion in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $23.7 billion in Q2 2026, $23.5 billion in Q1 2026, and $23.7 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 23.66 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 1.01 Bn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 12.65 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 6.00 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 1.79 Bn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 982.30 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 657.51 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 14.00 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 3.66 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 621,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.66 Bn |
| Mar 31, 2026 | 23.46 Bn |
| Dec 31, 2025 | 23.70 Bn |
| Sep 30, 2025 | 22.75 Bn |
| Jun 30, 2025 | 22.29 Bn |
| Mar 31, 2025 | 21.41 Bn |
| Dec 31, 2024 | 21.07 Bn |
| Sep 30, 2024 | 21.55 Bn |
| Jun 30, 2024 | 20.78 Bn |
| Mar 31, 2024 | 20.92 Bn |
| Dec 31, 2023 | 21.09 Bn |
| Sep 30, 2023 | 20.77 Bn |
| Jun 30, 2023 | 20.71 Bn |
| Mar 31, 2023 | 20.41 Bn |
| Dec 31, 2022 | 20.36 Bn |
| Sep 30, 2022 | 19.47 Bn |
| Jun 30, 2022 | 19.50 Bn |
| Mar 31, 2022 | 20.20 Bn |
| Dec 31, 2021 | 19.93 Bn |
| Sep 30, 2021 | 19.50 Bn |